Critical Congenital Heart Disease Newborn Screening Demonstration Program

by: TopGovernmentGrants Editorial Staff

The Health Resources and Services Administration, otherwise known as HRSA, is a federal government agency operating within the United States Department of Health and Human Services that is specifically responsible for improving the public's access to quality health care services, especially for those who are uninsured, isolated or medically vulnerable.

The grants and undertakings of the HRSA are all geared towards the attainment of its overall agency mission which is to "improve health and achieve health equity through access to quality services, a skilled health workforce and innovative programs."

In keeping with this mission, the Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

The program primarily aims to solicit applications comprising activities such as:

  (continued...)

Critical Congenital Heart Disease Newborn Screening Demonstration Program
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Zambia Economic Resilience Program for Improved Food Security
The Zambia Economic Resilience Program for Improved Food Security is designed to implement innovative techniques and approaches that would hopefully enable the community's most vulnerable and poor rural families to improve food security by strengthening their economic resilience.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Minority-Based Community Clinical Oncology Program Groups
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

---

Basic Research on HIV Persistence Program
In keeping with this mission, the National Institutes of Health has recently constituted the establishment of the Basic Research on HIV Persistence Program in an attempt to increase our understanding of the persistence of HIV-1 infections in patients under highly active anti-retroviral therapy (HAART).

---